AstraZeneca’s Strategic Acquisition of Icosavax: Pioneering the Future of Respiratory Vaccine Development
Key Highlights AstraZeneca acquires Icosavax, Inc., enhancing its position in respiratory vaccine development with the promising IVX-A12 vaccine.…